Registry of nerve-targeting heart treatment for fainting
Part of Brain & nervous system, Heart & circulation clinical trials.
This registry tracks people who receive a heart procedure called cardioneuroablation to stop severe fainting spells. The procedure targets nerve signals that cause the heart to pause, and researchers want to learn how well it works in real-world patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have had at least 2 fainting spells in the last year that are caused by a sudden drop in heart rate or blood pressure (vasovagal syncope).
- During one of these fainting spells, your heart was recorded to pause for 3 seconds or longer.
- You are scheduled to have a procedure called cardioneuroablation (a treatment that targets nerves to the heart to stop fainting).
- If you have a pacemaker, it must have at least 1 year of battery life left.
- You are covered by a national health insurance plan and agree to have your data used for this registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure called cardioneuroablation, which uses targeted heat (radiofrequency) to calm overactive nerves that cause your heart to beat too slowly and make you faint. The goal is to stop severe fainting spells in people with reflex syncope who haven't gotten better with other treatments.
This trial tests a procedure called cardioneuroablation to treat severe fainting (reflex syncope) that hasn't been helped by other treatments. The goal is to see if it reduces fainting without causing dangerous heart rhythm problems.
This study tests if a procedure called cardioneuroablation can help people who faint or feel like they're about to faint due to a slow heart rate. The treatment targets the nerves around the heart to improve heart rate control and exercise capacity.
This is a registry study that records information from people before they get a heart-related device implanted. It may help doctors understand how the team’s tests and planning relate to the procedure and outcomes later on.
This test uses a procedure to ablate (destroy) specific nerves in the heart that may be causing your heart to beat too slowly. The goal is to help your heart speed up naturally when needed, so you may avoid needing a permanent pacemaker.
This study compares a procedure called cardioneuroablation with staying on permanent pacing in people who have symptoms from a slow heart rate. It aims to see which approach works better and is safer for reducing symptoms related to sinus node or heart conduction problems.
Hear when a new Syncope, Vasovagal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.